Introduction {#S0001}
============

Biofilms are complex microbial communities which usually have a key role in virulence and antibiotic resistance in pathogenic bacteria \[[1](#CIT0001),[2](#CIT0002)\]. In numerous bacterial species, biofilm formation and maturation are regulated by quorum sensing (QS), a chemical communication system mediated by extracellular signals that are thought to enable bacteria to assess population size and coordinate virulence factor expression \[[3](#CIT0003)\]. Therefore, the inhibition of QS, a process known as quorum quenching (QQ), constitutes an interesting alternative for controlling pathogenic bacterial behaviours \[[4](#CIT0004)\]. Oral biofilms comprise about 500--1,000 species, almost half of them still uncultured \[[5](#CIT0005)\]. Among them, *Streptococcus* species are the initial colonizers of clean teeth surfaces and the main components of early dental plaque. Although *Streptococcus mutans* was considered one of the major cariogenic bacteria in humans in the past \[[6](#CIT0006),[7](#CIT0007)\], recent DNA- and RNA-based studies from carious lesions indicate that this bacterium represents only a small fraction of the bacterial community present in these lesions \[[8](#CIT0008)\]. Biofilm formation by *S. mutans* is regulated by two QS systems, although the hierarchy of their organization is unknown. The QS system typical of streptococci is regulated by a peptide pheromone signal called competence stimulating peptide (CSP) \[[9](#CIT0009)\], which is species-specific and detected by a histidine-kinase \[[10](#CIT0010)\]. The inactivation of any of the genes related to the CSP QS system results in the alteration of biofilm architecture \[[11](#CIT0011)\]. The other QS signal related to biofilm formation in *S. mutans* is AI-2 \[[7](#CIT0007),[12](#CIT0012),[13](#CIT0013)\], which has been proposed as a universal signalling molecule due to its wide distribution among prokaryotes \[[14](#CIT0014),[15](#CIT0015)\], including important oral pathogens \[[16](#CIT0016)\]. The mutation of the gene of *luxS* which codifies the enzyme required for AI-2 production affects biofilm formation in *S. mutans* \[[12](#CIT0012),[17](#CIT0017)\]. The QS signal AI-2 seems to be relevant also in other oral pathogens such as *Porphyromonas gingivalis, Aggregatibacteractinomycetencomitans* Y4, *Treponema denticola*, and *Tannerella forsythia* \[[7](#CIT0007),[18](#CIT0018)\], which indicates complex signalling networks in the oral biofilm. According to the hypothesis proposed by Kolenbrander et al. \[[19](#CIT0019)\], high levels of AI-2 would accelerate the growth of pathogens while reducing growth of commensal bacteria, contributing to subgingival plaque formation and maturation and leading to periodontal diseases. However, LuxS is also a central metabolic enzyme which plays a crucial role in methionine metabolism \[[20](#CIT0020)\] and participates in protein, RNA, and DNA synthesis \[[17](#CIT0017)\], and therefore, the effects observed when its gene is mutated have to be interpreted carefully. Furanones, which are known to inhibit communication based on acyl homoserine lactone (AHL) and AI-2 signals \[[21](#CIT0021)\], have been reported to affect biofilm formation in *S. mutans*. A previous study indicated that the biofilm inhibition observed in *S. mutans* supplemented with the furanone C52 is linked with the interference with AI-2-controlled processes \[[22](#CIT0022)\]. However, another study reported the inhibition of biofilm formation in *S. mutans* by the synthetic furanone C30 through an unknown mechanism not dependent of QS-signal AI-2, since the *luxS* mutant was also affected \[[23](#CIT0023)\]. In *S. pneumoniae*, the use of the natural compound Sinefungin, which interferes with AI-2 synthesis, also caused the alteration of the biofilm structure and a concentration-dependent inhibition in biofilm formation \[[24](#CIT0024)\].

Preliminary observations of anti-biofilm activity by *Tenacibaculum* sp. 20J against several Gram-positive and marine bacteria prompted us to study the capacity of cell extracts from 20J to interfere with communication mediated by the QS signal AI-2 and biofilm formation in the oral pathogen *S. mutans*. Surface-associated growth by *S. mutans* was monitored in real-time using the xCELLigence® technology that measures total biofilm biomass by combining both cellular growth and matrix production \[[25](#CIT0025)--[28](#CIT0028)\]. Moreover, confocal laser scanning microscopy (CLSM) as well as crystal violet biofilm staining were used to confirm xCELLigence® results.

Materials and methods {#S0002}
=====================

Bacterial strains and growth conditions {#S0002-S2001}
---------------------------------------

The Gram-positive biofilm forming bacteria *S. mutans* ATCC25175, *S. oralis* DSM20627, and S. *dentisani* 7747 were routinely cultured in brain heart infusion (BHI) broth or on BHI agar supplemented with 0.1% sucrose at 37°C. Biofilm formation by *S. mutans* was also assessed in BHI supplemented with both sucrose and glucose at 0.1% and 0.2%. The strain *Tenacibaculum* sp.20J CECT7426, isolated in our laboratory from a marine sample \[[29](#CIT0029)\], and *T. maritimum* NCIMB2154^T^ were routinely cultured at 22°C on Marine Agar/Broth pH 7.0 (MA/MB, Difco).

The strains used for the AI-2 bioassay, *Vibrio harveyi* BB170 (HAI-1 negative; AI-2 positive; CAI-1 positive), *V. harveyi* JMH597 (HAI-1 negative; AI-2 positive; CAI-1 negative) \[[30](#CIT0030)\], and *V. harveyi* JAF548, in which bioluminescence is not under the control of QS systems due to the permanent activation of the QS-dependent bioluminescence repressor LuxO \[[31](#CIT0031),[32](#CIT0032)\], were cultured in LB supplemented with 30 μg ml^−1^ of the antibiotic kanamycin (LB+Km) and in autoinducer bioassay medium (AB) \[[33](#CIT0033)\].

Cell extracts preparation {#S0002-S2002}
-------------------------

Purified cell extracts (PCEs) were obtained from 50 ml stationary-phase MB cultures of *Tenacibaculum* sp. strain 20J and *T. maritimum* NCIMB2154^T^. The cultures were centrifuged for 10 min at 5000 × g in order to separate the biomass from the culture media. The pellet was washed with 15 ml of phosphate buffered saline (PBS) pH 6.5, resuspended in 1.5 ml of the same buffer, sonicated for 5 min in ice, and centrifuged at 16,000 × g for 30 min at 4°C. The PCEs obtained in this way were filtered through 0.22 μm and stored at 4°C \[[34](#CIT0034)\]. Total protein concentration in the PCEs was estimated by Lowry's method \[[35](#CIT0035)\]. For the PCE of strain 20J, one aliquot was fractioned using Centricon® Centrifugal Filter Devices (Millipore Corporation, Bedford, MA) of 100 kDa (YM-100), 50 kDa (YM-50), and 10 kDa (YM-10). Filters were pre-washed with NaOH 0.1 N and deionized water. Aliquots of PCEs were also ultracentrifuged (20 min 300,000 g) or dialysed using D-tube^TM^ Dyalizer Mega (EMD Millipore Corp. Billerica, MA). The PCE (500 μl) was also extracted twice with an equal volume of ethyl acetate (EA-PCE 20J). For obtaining the methanolic cell extract (MCE), the biomass from a 50 ml culture of *Tenacibaculum* sp. 20J was resuspended in methanol (1.5 ml) and treated in the same way as the PCE. After centrifugation, an aliquot of the MCE was further extracted twice with an equal volume of dichloromethane (DM-MCE 20J). Solvents were evaporated to dryness in a rotary evaporator system at 40°C and resuspended in PBS pH 6.5.

The PCE of *Tenacibaculum* sp. 20J was also treated with proteinase K (100 μg ml^−1^; Sigma-Aldrich, MO) at 30°C for 1 h \[[36](#CIT0036)\]. Thermal stability of the bioactive compound was tested by incubating the PCE of *Tenacibaculum* sp. 20J at 100°C for 10 min \[[36](#CIT0036)\]. The residual anti-biofilm activity was measured by using the xCELLigence® System RTCA (ACEA, Biosciences Inc., CA).

Bioluminescence assay {#S0002-S2003}
---------------------

*V. harveyi* BB170 (HAI-1 negative; AI-2 positive; CAI-1 positive), *V. harveyi* JMH597 (HAI-1 negative; AI-2 positive; CAI-1 negative), and the QS-independent bioluminescent strain *V. harveyi* JAF548 were used as biosensor strains \[[30](#CIT0030)--[32](#CIT0032)\]. They were grown overnight in MB at 30°C with shaking. Aliquots of these overnight cultures were diluted 1:5,000 into fresh AB medium (modified from \[[30](#CIT0030)\]). In each well of a 96-well black microtiter plate, 180 µl of *V. harveyi* dilution and 20 µl of tested compounds were added. Photographs were taken every hour using the Gel Doc^TM^ XR+ system Bio Rad equipment. Experiments were performed in triplicate. The effect of the cell extracts on growth of the biosensor strains was monitored measuring the optical density at 600 nm under same conditions as the bioluminescence assay.

Biofilm measurement and analysis {#S0002-S2004}
--------------------------------

The biofilm quantification was done using the xCELLigence® System RTCA (ACEA, Biosciences Inc.) \[[25](#CIT0025)--[28](#CIT0028)\], in which the increase in the cell adherence on the electrodes causes an increase in the electrode impedance, which is expressed into a dimensionless parameter called cell index. E-plates 16 or E-plate 96 (ACEA, Biosciences Inc.) were inoculated with 180 μl of a 24-h culture of *S. mutans* in BHI broth supplemented with 0.1% sucrose (OD~600~ adjusted to 0.05) and 20 μl of extracts or inhibitors. Furanone C30 (0.02 µg ml^−1^, Sigma-Aldrich) and the AHL-lactonase Aii20J (20 µg ml^−1^ \[[36](#CIT0036)\]) were also tested. Twenty microlitres of PBS pH 6.5 were added to the control wells. The system was incubated at 37°C for 24 h.

Biofilms of *S. mutans* were allowed to form on glass coverslips (18 × 18 mm) using 12-well cell-culture plates containing 3 mL of BHI broth supplemented with 0.1% sucrose (modified from \[[37](#CIT0037)\]). After incubation, the supernatant was removed, wells were rinsed with PBS to remove the planktonic cells, and the biofilms were stained with either crystal violet or with Syto9 (Thermofisher Scientific) for CLSM observation. For crystal violet quantification \[modified from \[[38](#CIT0038)\]\], ethanol was added for the fixation of the biofilms, and after 15 min the supernatant was removed again. Then, 0.1% crystal violet (Gram-Hucker, Panreac) solution was added to all wells, and after 20 min, the excess of dye was removed washing several times. Bound crystal violet was released by adding 33% acetic acid. The absorbance was measured at 590 nm. The results are expressed in terms of percentage of biofilm formed in the presence of extracts in comparison with untreated wells. All experiments were performed in triplicate.

Microscopic observation was performed using a Leica TSC SP2 laser scanning spectral confocal microscope (Leica Microsystem Heidelberg GmbH, Mannheim, Germany) with an HCX PL APO 63x/1.3 Gly. Eight randomly selected fields of each sample were evaluated. The optical sections were scanned in 1-µm sections from the surface of the biofilm to its base, measuring the maximum thickness of the field and subsequently the mean thickness of the biofilm of the corresponding sample. The quantification of the percentage of coverage surface (µm^2^) was obtained comparing the total surface of the field with the bacterial biofilm. A Nikon Eclipse E400 microscope equipped with a Leica MC170 HD camera was used to image the biofilms stained with crystal violet.

Bacterial growth inhibition {#S0002-S2005}
---------------------------

The effect of the cell extracts (100 μg ml^−1^) and furanone (0.02 μg ml^−1^) on planktonic growth was investigated by comparing bacterial growth measured at 600 nm with control cultures after 24 h of incubation. Cultures were mixed vigorously with a pipette in order to detach the bacteria. BHI medium supplemented with 0.1% sucrose and the inoculum of *S. mutans* without PCE were used as controls. All experiments were performed in triplicate. Antimicrobial activity of the cell extracts was also assayed by the disc diffusion test which was performed on BHI agar. Sterile discs (Liofilchem®) with a diameter 6 mm were loaded with 20 µl of the cell extracts and the discs placed over plates inoculated with *S. mutans*. Plates were then incubated at 37°C for 24 h and checked for the presence of inhibitory halos.

Ahl-degradation activity bioassay {#S0002-S2006}
---------------------------------

The AHL degradation activity of the different extracts was tested by incubating 500 μl of each extract with *N*-hexanoyl-L-homoserine lactone (C6-HSL) 10 μM for 24 h at 22°C 200 rpm and the remaining AHL was detected using the biosensor strain *Chromobacterium violaceum* CV026 \[[39](#CIT0039),[40](#CIT0040)\]. After 24 h of degradation, 100 μl of the mixture were placed in wells made on an LB plate overlaid with a 1/100 dilution of an overnight culture of *C. violaceum* CV026 in soft LB (8% agar). The plates were incubated for 24 h at 30°C and the production of violacein was observed. As control, wells were filled with 100 μl of sterile PBS plus C6-HSL treated as samples.

Statistical analyses {#S0002-S2007}
--------------------

The student *t*-test was performed to determine the statistical significance of the differences in cell index and bacterial growth by *S. mutans* between the control and the treated wells. Significant differences were determined at *P *\< 0.05.

Results {#S0003}
=======

Cell extracts of *Tenacibaculum* sp. 20J interfere with AI-2 signalling {#S0003-S2001}
-----------------------------------------------------------------------

To assess the interference with AI-2-mediated communication, a cell extract from *Tenacibaculum* sp. 20J was obtained and tested with the reporter strains *V. harveyi* BB170, in which bioluminescence is under the control of the AI-2 and CAI-1 QS systems, and *V. harveyi* JMH597 that only senses the AI-2 signal \[[30](#CIT0030)\]. To exclude that 20J-PCE affects bioluminescence in *V. harveyi* through factors nondependent on QS, the mutant *V. harveyi* JAF548 \[[31](#CIT0031)\] in which bioluminescence is expressed independently of QS control was used. Moreover, the Furanone C30, which was suggested to prevent biofilm formation in *S. mutans* previously \[[22](#CIT0022),[23](#CIT0023)\], and extracts obtained from the closely related species *T. maritimum* NCBI2154^T^, a strain with no AHL-lactonase activity \[[36](#CIT0036)\], were also tested. Results showed that after 8 h, the 20J extract completely eliminates light production by the reporters BB170 and JMH597 compared to control wells ([Figure 1(a)](#F0001)). This delay was not caused by a delay in growth since the growth curves of the cultures were identical (data not shown). As expected, the AHL-lactonase Aii20J, that is present in the cell extract, had no effect on the luminescence produced by the reporter BB170. Surprisingly, the addition of the lactonase accelerated the production of bioluminescence in *V. harveyi* JMH597 ([Figure 1(a)](#F0001)). Neither the Furanone C30 nor the extracts of *T. maritimum* NCBI2154^T^ showed bioluminescence inhibitory activity on BB170 at the concentrations tested. Since the addition of 20J extracts did not cause any change in the production of bioluminescence in the reporter JAF548, these results suggest the presence of an AI-2 specific inhibitory activity in *Tenacibaculum* sp. 20J. The inhibition is not present in the methanolic biomass extract (MCE) of the same species ([Figure 1(b)](#F0001)).Figure 1.Effect of QS inhibitors and extracts on bioluminescence production by different *V. harveyi* reporter strains in 96-well cell culture plates. (A) Bioluminescence assays using *V. harveyi* BB170 (AHL−, AI2+, CAI+) and *V. harveyi* JMH597 (AHL−, AI2+, CAI−) with furanone (0.02 µg ml^−1^), the AHL-lactonase Aii20J (20 μg ml^−1^), and the purified cell extracts from *Tenacibaculum* sp. 20J (PCE20J) and *T. maritimum* (PCE*Tm*) (100 μg ml^−1^). (B) Effect of purified cell extract (PCE) and methanolic cell extract on bioluminescence production by *V. harvery* BB170, JMH597, and the QS independent strain JAF548. Assays were carried out in triplicate. Only one well is shown for each condition.

*Tenacibaculum* sp. 20J extracts affect biofilm formation in streptococcus mutans {#S0003-S2002}
---------------------------------------------------------------------------------

In order to study whether the AI-2 inhibitory activity found in *Tenacibaculum* sp. 20J extracts could prevent biofilm formation in *S. mutans*, extracts of strain 20J and *T. maritimum* were added to cultures of the pathogen and biofilm formation was assessed using the xCELLigence® system. A reduction of 50% in the cell index, the parameter that indicates biofilm formation, was observed when 20J extract was added to *S. mutans* cultures ([Figure 2](#F0002)). On the other hand, although some reduction of cell index was recorded in cultures supplemented with *T. maritimum* extracts, this effect was not significant (*P *\> 0.05) ([Figure 2](#F0002)). Furanone C30 did not cause any reduction in attachment by *S. mutans* at the concentration tested (0.02 μg ml^−1^) as measured with the xCELLigence® system ([Figure 2](#F0002)). As expected, the AHL-lactonase Aii20J did not display anti-biofilm activity against *S. mutans*. No effect on *Staphylococcus aureus* biofilm formation could be observed in treated cultures, indicating the presence of a specific biofilm inhibitory activity against *S. mutants* in 20J extracts (data not shown).Figure 2.Biofilm formation by *Streptococcus mutans* as measured by xCELLigence® system (■). The effect of purified cell extracts from *Tenacibaculum* sp. 20J (∆), *T. maritimum* NCIMB2154^T^ (◊) (100 μg ml^−1^); furanone C30 (○)(0.02 μg ml^−1^) and the AHL lactonase Aii20J (˟) (20 μg ml^−1^) were tested (*n* = 3).

Optical densities of shaken cultures of *S. mutans* were measured to evaluate whether the reduction in biofilm formation in cultures supplemented with 20J extracts was derived from growth inhibition. The addition of 20J extracts in *S. mutans* cultures showed a biofilm inhibition of 50% in the cell index ([Figure 3(a)](#F0003)), but it had no significant effect (*P *\> 0.05) on bacterial growth ([Figure 3(b)](#F0003)). To further verify that the inhibitory activity on biofilm formation does not result from reducing *S. mutans* growth, disc diffusion assays were performed with 20J extracts. As a result, no growth inhibition halos around the discs could be observed (data not shown) confirming the absence of growth inhibitory activity against *S. mutans* in the cell extract of strain 20J.Figure 3.Effect of cell extracts of *Tenacibaculum* sp. 20J, *T. maritimum* (100 μg ml^−1^) and furanone (0.02 μg ml^−1^) on biofilm formation (A) and cell growth (B). Data were measured as cell index (biofilm growth) and OD~600~ (cell growth) of *S. mutans* in comparison to control cultures (100%). Experiments were performed in triplicate.

The biofilm inhibition is not dependent of the culture media {#S0003-S2003}
------------------------------------------------------------

The culture media BHI was supplemented with two concentrations of sucrose and glucose (0.1% and 0.2%). Biofilm formation without sugar supplementation was too low to be reliably detected by the xCELLigence® system (cell index below 0.05). The increase in the concentration of both sugars enhanced the adhesion of *S. mutans* cells, with the highest cell index being achieved with sucrose 0.2% ([Figure 4](#F0004)). The 20J extract inhibited biofilm formation in all conditions, with a reduction of 50% of cell index in both sucrose concentrations and with 0.2% glucose ([Figure 4](#F0004)).Figure 4.Effect of the cell extract of *Tenacibaculum* sp. 20J (100 μg ml^−1^) on *S. mutans* cultures inoculated with different sucrose (0.1% and 0.2%) and glucose (0.1% and 0.2%) concentrations. Data were measured as cell index (biofilm growth) of *S. mutans* in comparison to control cultures (100%). Experiments were performed in triplicate.

Validation of xCELLigence® system results {#S0003-S2004}
-----------------------------------------

To validate the biofilm formation results obtained with the xCELLigence® system, biofilm formation by *S. mutans* cultures supplemented with the 20J extract was studied using epifluorescence and CLSM as well as crystal violet staining assays. The CLSM observation showed lower coverage and smaller microcolonies in 20J extract-treated cultures of *S. mutans* confirming the data obtained with the xCELLigence® system. The addition of the AHL-QQ enzyme Aii20J did not cause significant changes in the structure of the biofilm (data not shown). An average reduction of more than 50% in *S. mutans* biofilm formation could also be recorded in the culture supplemented with 20J extract used for CLSM analysis, although estimation of the surface coverage using this technique is difficult due to the non-uniform surface coverage ([Figure 5](#F0005)). A significant decrease in the biofilm thickness was also observed in the plates (51.38%). The observation of slides stained with crystal violet also revealed important differences in the area coverage and the shape of the cell aggregates between control and 20J-treated biofilms cultured under standard conditions but the quantification showed no differences in biofilm formation (data not shown). However, a decrease of 25% could be observed in *S. mutans* supplemented with PCE20J using the crystal violet staining assay ([Figure 6](#F0006)) when the biofilm formation was promoted by changing the culture media twice a day.Figure 5.Confocal microscope observation (63 ×) of the effect of the addition of the cell extract if strain 20J (PCE20J) on biofilm formation by *S. mutans*. The highest and the lowest covered surface fields among the eight fields analysed per sample are shown. A reduction of at least 50% of covered surface is observed in the presence of PCE20J. Figure 6.Biofilm formation quantified by crystal violet staining by *S. mutans, S. oralis*, and *S. dentisani* in absence or presence of the cell extract of strain 20J (PCE20J). Experiments were performed in triplicate.

Biofilm formation is also affected in other oral *Streptococcus* species {#S0003-S2005}
------------------------------------------------------------------------

In order to know whether the activity of PCE20J observed in *S. mutans* is specific, the anti-biofilm properties of the cell extract were also tested in other oral streptococci. Biofilm formation in *S. oralis* and *S. dentisani* was too low to be accurately measured with the xCELLigence® system. The treatment with PCE20J caused a decrease of almost 40% in *S. oralis* DSM20627 and *S. dentisani* 7747 ([Figure 6](#F0006)).

Characterization of the bioactive component of purified cell extract from *Tenacibaculum* sp. 20J {#S0003-S2006}
-------------------------------------------------------------------------------------------------

To perform a preliminary characterization of the anti-biofilm compound(s) present in the biomass of strain 20J, different 20J extracts were obtained using methanol, ethyl-acetate, and dichloromethane and tested for anti-biofilm activity against *S. mutans*. No effect on biofilm formation or bacterial growth was recorded for any of the extracts obtained with organic solvents, suggesting that a polar molecule is responsible for the anti-biofilm activity ([Figure 7](#F0007)). Moreover, 20J extract fractions with molecular weights below 100 kDa showed no effect on *S. mutans* attachment ([Figure 8(a)](#F0008)), hence either a large molecule should be responsible for the inhibition of biofilm formation in this bacterium or the activity is membrane-bound. To confirm these results, extracts of 20J were either submitted to ultracentrifugation (20 min at 300,000 g) to remove large-size particles or dialyzed to remove molecules smaller than 8 kDa from the extracts. The anti-biofilm activity in dialyzed extracts was similar to that of whole 20J extracts, confirming the high molecular weight of the bioactive compound ([Figure 7(a)](#F0007)). While retaining the anti-biofilm activity, the dialyzed extract had no growth-inhibitory activity ([Figure 7(b)](#F0007)). Interestingly, a significant loss of anti-biofilm activity was recorded in supernatants from ultracentrifuged extracts (*P *\< 0.05), suggesting that the bioactive compound could be membrane-bound. The same extracts were assayed against the AHL C6-HSL in order to verify the dialysis and ultracentrifugation steps. Expectedly, due to the soluble nature of the AHL-lactonase enzyme present in 20J, dialyzed and ultracentrifuged extracts retained the AHL degradation activity. A 20J extract was then heat-inactivated at 100°C for 10 min or subjected to a proteinase K digestion at 30°C for 1 h. None of the treatments could eliminate the anti-biofilm activity present in the extract ([Figure 8(b)](#F0008)), suggesting that either a compound of non-protein nature or a highly resistant enzyme could be responsible for the anti-biofilm activity.Figure 7.Biofilm formation measured by xCELLigence® (A) and cell growth (B). Measures were done as cell index (biofilm growth) and OD~600~ (cell growth) of *S. mutans* in comparison to control cultures (100%). Different types of extracts from *Tenacibaculum* sp. 20J obtained using different solvents such as methanol (MCE), ethylacetate (EA-PCE) and dichlorometane (DM-MCE20J), and dialyzed PCE and ultracentrifuged PCE were tested as anti-biofilm compounds (*n* = 3). Figure 8.Effect of different treatments on the anti-biofilm activity of the cell extract of strain 20J (100 μg ml^−1^) against *S. mutans* measured by xCELLigence® system (■). (A) Activity of extracts fractionated by molecular weight \<100 kDa (□), the \<50 kDa (○), and the \<10 kDa (◊). (B) Effect of temperature (●) (100°C, 10 min) and treatment with proteinase K (▲)(1 h at 30°C) on the activity of the PCE. All cultures were carried out in triplicate.

Discussion {#S0004}
==========

*Tenacibaculum* sp. 20J was selected as a candidate with possible anti-AI-2 activity due to preliminary observations of anti-biofilm activity in Gram-positive and marine biofilm-forming bacteria not sensitive to the action of the AHL-QQ enzyme Aii20J. The results indicated that the aqueous PCE of *Tenacibaculum* sp. 20J is able to interfere specifically with the QS system AI-2, in a manner that is independent of the AHL-degradation capacity. The concentration of AI-2 in the culture media of *V. harveyi* can achieve up to 22.4 μM after 6.5 h of culture \[[41](#CIT0041)\], therefore the delay in bioluminescence production observed in the first 10 h of growth of cultures supplemented with *Tenacibaculum* sp. 20J extracts without affecting growth kinetics strongly suggests the presence of AI-2-inhibitory activity in strain 20J extracts. Importantly, 20J extracts did not affect bioluminescence in *V. harveyi* JAF548, in which bioluminescence is independent of the QS circuits \[[31](#CIT0031)\], indicating that bioluminescence production was not influenced by unspecific environmental factors \[[42](#CIT0042),[43](#CIT0043)\].

Given that biofilm formation is regulated by AI-2 signalling in *S. mutans* \[[7](#CIT0007),[12](#CIT0012),[13](#CIT0013)\], we decided to assess whether 20J extracts could interfere with biofilm formation of this early dental plaque colonizer. Indeed, the biofilm-inhibitory activity recorded in extracts of strain 20J suggested that it could be derived from the interference with the AI-2 QS system in *S. mutans*. The reduction of *S. mutans* biofilm formation is not resulting from growth inhibition since dialyzed extracts retained the anti-biofilm activity and favoured planktonic growth in comparison to untreated and control cultures. A preliminary analysis, including dialysis and ultracentrifugation, indicated that the active compound in 20J extracts is a large, possibly membrane-associated molecule. Despite the bioactive molecule is not affected by heat treatment and proteinase K digestion, it cannot be disregarded that the anti-biofilm activity is enzymatic since similar treatments could not neutralize enzymatic AHL degradation in 20J extracts \[[36](#CIT0036)\].

In this work, we corroborate previous results that indicate the suitability of the xCELLigence® system RTCA to monitor biofilm formation in *S. mutans* and other Gram-positive bacteria \[[25](#CIT0025)--[28](#CIT0028)\]. The xCELLigence® system constitutes a low time-consuming method for real-time quantification and continuous scrutiny of bacterial cell adhesion, in contrast to methods based on staining, microscopic visualization, quantification of biofilm-associated cells *in situ*, or after detachment from the substrate, and indirect methods such as DNA quantification, XTT reduction assay, or dry cell weight assay which are usually end-point techniques. The inhibitory effect of 20J extracts against *S. mutans* biofilm formation recorded with the xCELLigence® system was confirmed by microscope observation of crystal violet and fluorescence-stained biofilms indicating the suitability of this technology for monitoring bacterial biofilm. However, the crystal violet quantification method could only detect differences between 20J extract-treated and untreated *S. mutans* cultures when a thick biofilm formation is promoted by culture medium renewal, being therefore less sensitive than the xCELLigence® system.

Furanone C30 at a concentration of 0.02 μg ml^−1^ had no effect on biofilm formation by *S. mutans* as assessed by the xCELLigence® system. Furanone has been reported as a QS inhibitor that affects biofilm formation in *S. mutans* using the safranine staining and MTT \[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide\] assays as quantification methods \[[22](#CIT0022),[23](#CIT0023)\], although the active concentrations (0.15--4 μg ml^−1^) were significantly higher than those assayed in the present study (0.02 μg ml^−1^) and close to the toxicity threshold for this molecule that has been established at concentrations ≥1 µM (0.2 μg ml^−1^) \[[44](#CIT0044)\]. He et al. \[[23](#CIT0023)\] indicate that the furanone acts through an unknown mechanism not dependent of the production of the QS-signal AI-2 since it affected not only *S. mutans* but also the *luxS* mutant strain. In any case, the toxicity described for these molecules, causing the rapid death of fish \[[44](#CIT0044)\], and the development of resistance to furanone-based QS inhibitors \[[45](#CIT0045)\] exclude the use of these molecules as antimicrobial agents.

Several reports describe the inhibition of biofilm formation by *S. mutans* through the interference with the AI-2 QS system reducing significantly the biomass, the average depth, and the maximum depth of the biofilm \[[18](#CIT0018)\]. However, the structure of the AI-2 produced by streptococci is unknown \[[22](#CIT0022)\], more studies being needed to understand the interference of 20J extracts and other inhibitors with the AI-2 QS system in this species. Although additional experiments using mixed species models would be required in order to evaluate the potential of 20J extracts to prevent dental plaque formation and to control the progress of oral chronic infections such as periodontitis, the inhibition of the biofilm formation observed in another two oral streptococci, *S. oralis* and *S. dentisani*, indicates a wide spectrum activity.

Recent studies indicate that the QS networks in *S. mutans* are complex and should be explored in mixed biofilms in which other QS signals could be present \[[46](#CIT0046)--[48](#CIT0048)\]. The potential use of QQ strategies like 20J extracts to prevent biofilm formation by *S. mutans* and other oral pathogens is an attractive alternative since these approaches do not interfere with bacterial growth and hence, the probabilities of inducing resistance or tolerance against these mechanisms are lower. Also the broad spectrum QQ activity present in the cell extracts of *Tenacibaculum* sp. 20J, interfering with both AI-2 and AHL QS signals, could be applied to prevent mono and multi-species biofilms.
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